Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novartis (RNAi Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of RNAi therapeutics products. The business engages in RNAi research and development and formatting and modifications to develop a drug to wipe out disease-causing proteins.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Lichtstrasse 35
  • 4056 Basel
  • Switzerland

Novartis (RNAi Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novartis (RNAi Business)‘s full profile, request access.

Request full access to PitchBook

Novartis (RNAi Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novartis (RNAi Business)‘s full profile, request access.

Request full access to PitchBook